Financial Ratios Narayana Hrudayalaya Limited
Equities
NH
INE410P01011
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,754.90 INR | +1.54% |
|
+7.99% | -7.25% |
| 20/02 | Narayana Hrudayalaya purchases 3.3 acres of land | RE |
| 17/02 | Narayana Hrudayalaya Limited, Q3 2026 Earnings Call, Feb 17, 2026 |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 0.28 | 10.2 | 13.15 | 11.7 | 9.72 | |||||
Return on Total Capital | 0.38 | 14.4 | 18.33 | 15.21 | 11.86 | |||||
Return On Equity % | -1.27 | 26.21 | 33.5 | 31.47 | 24.25 | |||||
Return on Common Equity | -1.27 | 26.21 | 33.49 | 31.48 | 24.25 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 25.02 | 32.78 | 37 | 37.23 | 38.52 | |||||
SG&A Margin | 4.21 | 3.56 | 3.9 | 4.25 | 4.37 | |||||
EBITDA Margin % | 5.73 | 16.73 | 20.55 | 22.04 | 22.4 | |||||
EBITA Margin % | 0.84 | 13.25 | 17.43 | 18.9 | 18.88 | |||||
EBIT Margin % | 0.48 | 13 | 16.94 | 18.25 | 18.29 | |||||
Income From Continuing Operations Margin % | -0.55 | 9.24 | 13.39 | 15.73 | 14.4 | |||||
Net Income Margin % | -0.55 | 9.24 | 13.38 | 15.73 | 14.41 | |||||
Net Avail. For Common Margin % | -0.55 | 9.24 | 13.38 | 15.73 | 14.4 | |||||
Normalized Net Income Margin | -1.2 | 7.25 | 10.21 | 11 | 10.57 | |||||
Levered Free Cash Flow Margin | 4.89 | 2.4 | 1.13 | -3.21 | -7.74 | |||||
Unlevered Free Cash Flow Margin | 6.71 | 3.51 | 2.08 | -2 | -6.07 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.91 | 1.25 | 1.24 | 1.03 | 0.85 | |||||
Fixed Assets Turnover | 1.35 | 1.95 | 2.13 | 1.92 | 1.56 | |||||
Receivables Turnover (Average Receivables) | 8.75 | 9.4 | 9.32 | 10.35 | 9.99 | |||||
Inventory Turnover (Average Inventory) | 35.93 | 46.41 | 43.58 | 34.71 | 30.62 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.95 | 1.17 | 1.31 | 1.75 | 2.14 | |||||
Quick Ratio | 0.75 | 0.99 | 0.93 | 1.45 | 1.89 | |||||
Operating Cash Flow to Current Liabilities | 0.44 | 0.62 | 1.1 | 0.96 | 0.83 | |||||
Days Sales Outstanding (Average Receivables) | 41.72 | 38.85 | 39.18 | 35.37 | 36.54 | |||||
Days Outstanding Inventory (Average Inventory) | 10.16 | 7.86 | 8.37 | 10.55 | 11.92 | |||||
Average Days Payable Outstanding | 73.02 | 62.75 | 67.76 | 69.94 | 63.77 | |||||
Cash Conversion Cycle (Average Days) | -21.15 | -16.03 | -20.21 | -24.03 | -15.31 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 75.14 | 48.76 | 41.46 | 56.38 | 66.93 | |||||
Total Debt / Total Capital | 42.9 | 32.78 | 29.31 | 36.05 | 40.09 | |||||
LT Debt/Equity | 61.56 | 38.26 | 33.53 | 46.61 | 59 | |||||
Long-Term Debt / Total Capital | 35.15 | 25.72 | 23.7 | 29.8 | 35.34 | |||||
Total Liabilities / Total Assets | 59.54 | 52.41 | 48.77 | 48.71 | 50.06 | |||||
EBIT / Interest Expense | 0.17 | 7.34 | 11.11 | 9.45 | 6.85 | |||||
EBITDA / Interest Expense | 2.52 | 10.08 | 14.1 | 11.91 | 8.7 | |||||
(EBITDA - Capex) / Interest Expense | 1.59 | 6.25 | 6.54 | 1.9 | 1.3 | |||||
Total Debt / EBITDA | 4.43 | 1.1 | 0.91 | 1.41 | 1.91 | |||||
Net Debt / EBITDA | 3.27 | 0.66 | 0.49 | 0.45 | 0.64 | |||||
Total Debt / (EBITDA - Capex) | 7.02 | 1.77 | 1.96 | 8.86 | 12.71 | |||||
Net Debt / (EBITDA - Capex) | 5.18 | 1.07 | 1.06 | 2.85 | 4.29 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -17.44 | 43.24 | 22.38 | 10.79 | 12.12 | |||||
Gross Profit, 1 Yr. Growth % | -33.83 | 88.9 | 38.14 | 11.46 | 14.68 | |||||
EBITDA, 1 Yr. Growth % | -61.49 | 333.48 | 50.34 | 18.84 | 11.46 | |||||
EBITA, 1 Yr. Growth % | -91.56 | 2.96T | 61 | 20.11 | 9.56 | |||||
EBIT, 1 Yr. Growth % | -94.94 | 6.91T | 59.45 | 19.38 | 9.9 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -112.01 | -2.49T | 77.3 | 30.18 | 0.49 | |||||
Net Income, 1 Yr. Growth % | -112.03 | -2.49T | 77.3 | 30.19 | 0.11 | |||||
Normalized Net Income, 1 Yr. Growth % | -128.14 | -962.84 | 72.47 | 19.18 | 5.52 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -112.03 | -2.49T | 77.26 | 30.18 | 0.47 | |||||
Accounts Receivable, 1 Yr. Growth % | 8.49 | 56.51 | 2.05 | -2.31 | 29.04 | |||||
Inventory, 1 Yr. Growth % | -20.59 | 24.12 | 20.54 | 53.62 | 0.28 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -5.65 | 4.08 | 19.31 | 26.03 | 40.97 | |||||
Total Assets, 1 Yr. Growth % | -4.19 | 12.99 | 32.95 | 35.14 | 29.17 | |||||
Tangible Book Value, 1 Yr. Growth % | 0.02 | 38.07 | 34.11 | 42.58 | 28.56 | |||||
Common Equity, 1 Yr. Growth % | -1.38 | 32.88 | 43.18 | 35.3 | 25.75 | |||||
Cash From Operations, 1 Yr. Growth % | -30.29 | 59.41 | 123.61 | -1.66 | -7.58 | |||||
Capital Expenditures, 1 Yr. Growth % | -39.51 | 257.6 | 108.25 | 85.92 | 11.47 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -46.9 | -27.69 | -43.11 | -415.32 | 1.28T | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -40.4 | -23.63 | -27.92 | -206.64 | -1.21T | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | 150 | 60 | 12.5 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -5.08 | 8.63 | 32.4 | 16.44 | 10.02 | |||||
Gross Profit, 2 Yr. CAGR % | -13.7 | 11.31 | 61.53 | 24.08 | 12.25 | |||||
EBITDA, 2 Yr. CAGR % | -29.16 | 26.71 | 155.28 | 33.67 | 14.88 | |||||
EBITA, 2 Yr. CAGR % | -64.44 | 38.11 | 601.83 | 39.06 | 14.5 | |||||
EBIT, 2 Yr. CAGR % | -72.22 | 39.33 | 957.21 | 37.96 | 14.32 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -50.89 | 69.52 | 551.42 | 51.92 | 14.11 | |||||
Net Income, 2 Yr. CAGR % | -50.83 | 69.57 | 551.02 | 51.93 | 14.16 | |||||
Normalized Net Income, 2 Yr. CAGR % | -27.32 | 55.82 | 285.77 | 43.43 | 11.89 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -50.85 | 69.52 | 550.73 | 51.91 | 14.1 | |||||
Accounts Receivable, 2 Yr. CAGR % | 2.83 | 30.31 | 26.38 | -0.15 | 12.28 | |||||
Inventory, 2 Yr. CAGR % | -24.17 | -0.72 | 22.31 | 36.08 | 24.12 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 3.2 | -0.9 | 11.44 | 22.62 | 33.29 | |||||
Total Assets, 2 Yr. CAGR % | 2.49 | 4.05 | 22.58 | 34.04 | 32.12 | |||||
Tangible Book Value, 2 Yr. CAGR % | 3.85 | 17.52 | 36.08 | 38.28 | 35.39 | |||||
Common Equity, 2 Yr. CAGR % | 1.79 | 14.48 | 37.93 | 39.18 | 30.44 | |||||
Cash From Operations, 2 Yr. CAGR % | 5.31 | 4.59 | 88.8 | 48.29 | -4.66 | |||||
Capital Expenditures, 2 Yr. CAGR % | -31.64 | 47.08 | 172.89 | 96.77 | 43.96 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 29.46 | -38.91 | -35.56 | 33.94 | 188.25 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 20.3 | -33.22 | -25.57 | -12.33 | 87.93 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | 0 | - | 100 | 34.16 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 4.12 | 8.8 | 13.03 | 24.77 | 14 | |||||
Gross Profit, 3 Yr. CAGR % | -2.29 | 11.72 | 19.62 | 42.74 | 20.29 | |||||
EBITDA, 3 Yr. CAGR % | -13.16 | 27.89 | 34.14 | 97.85 | 25.65 | |||||
EBITA, 3 Yr. CAGR % | -45.54 | 41.9 | 45.35 | 289.65 | 28.28 | |||||
EBIT, 3 Yr. CAGR % | -53.99 | 43.6 | 45.73 | 410.99 | 27.73 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -34.73 | 79.38 | 72.07 | 280.85 | 32.16 | |||||
Net Income, 3 Yr. CAGR % | -34.69 | 79.45 | 72.11 | 280.7 | 32.21 | |||||
Normalized Net Income, 3 Yr. CAGR % | -14.96 | 65.79 | 61.18 | 160.86 | 29.29 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -34.69 | 79.38 | 72.06 | 280.59 | 32.15 | |||||
Accounts Receivable, 3 Yr. CAGR % | 0.67 | 18.28 | 20.11 | 15.99 | 8.76 | |||||
Inventory, 3 Yr. CAGR % | -16.99 | -10.63 | 5.91 | 31.97 | 22.91 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 2.32 | 3.49 | 5.42 | 16.1 | 28.46 | |||||
Total Assets, 3 Yr. CAGR % | 2.99 | 5.88 | 12.92 | 26.63 | 32.4 | |||||
Tangible Book Value, 3 Yr. CAGR % | 4.37 | 14.19 | 22.81 | 38.21 | 34.96 | |||||
Common Equity, 3 Yr. CAGR % | 2.65 | 11.25 | 23.34 | 37.05 | 34.55 | |||||
Cash From Operations, 3 Yr. CAGR % | 19.25 | 20.29 | 34.74 | 51.91 | 26.67 | |||||
Capital Expenditures, 3 Yr. CAGR % | -29.93 | 18.67 | 65.16 | 140.13 | 62.82 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 9.02 | 5.61 | -40.16 | 9.4 | 67.83 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 35.25 | 2.68 | -31.36 | -16.09 | 36.54 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | 0 | 35.72 | - | 65.1 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 9.87 | 14.41 | 14.57 | 11.79 | 11.82 | |||||
Gross Profit, 5 Yr. CAGR % | -4.77 | 14.51 | 19.26 | 16.51 | 16.61 | |||||
EBITDA, 5 Yr. CAGR % | -3.43 | 20.75 | 32.63 | 30.17 | 26.08 | |||||
EBITA, 5 Yr. CAGR % | -26.81 | 24.56 | 42.49 | 40.76 | 32.12 | |||||
EBIT, 5 Yr. CAGR % | -34.42 | 24.09 | 42.9 | 41.32 | 32.25 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -7.24 | 32.75 | 63.82 | 67.84 | 46 | |||||
Net Income, 5 Yr. CAGR % | -7.6 | 32.71 | 63.84 | 67.89 | 46.05 | |||||
Normalized Net Income, 5 Yr. CAGR % | -4.51 | 25.04 | 55.71 | 56.46 | 39.31 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -7.82 | 32.72 | 63.82 | 67.84 | 45.99 | |||||
Accounts Receivable, 5 Yr. CAGR % | 13.25 | 23.16 | 10.26 | 10.53 | 16.92 | |||||
Inventory, 5 Yr. CAGR % | -0.78 | 2.55 | -3.06 | 5.74 | 12.85 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 13.1 | 12.53 | 5.87 | 10.76 | 15.79 | |||||
Total Assets, 5 Yr. CAGR % | 12.22 | 13.7 | 10.42 | 16.36 | 20.24 | |||||
Tangible Book Value, 5 Yr. CAGR % | 4.12 | 8.8 | 16.05 | 23.28 | 27.69 | |||||
Common Equity, 5 Yr. CAGR % | 5.04 | 9.1 | 15.53 | 21.68 | 26.13 | |||||
Cash From Operations, 5 Yr. CAGR % | 12.17 | 17.2 | 42.86 | 30.79 | 17.33 | |||||
Capital Expenditures, 5 Yr. CAGR % | -4.97 | 13.17 | 20.71 | 45.27 | 56.33 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 19.66 | 2.63 | -12.16 | 16.35 | 12.23 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 20.34 | 7.33 | 6.07 | -3.49 | 2.7 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | - | 31.95 | 35.1 |
- Stock Market
- Equities
- NH Stock
- Financials Narayana Hrudayalaya Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















